These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5149 related articles for article (PubMed ID: 3546184)

  • 21. Mechanism of protein synthesis inhibition by didemnin B in vitro.
    SirDeshpande BV; Toogood PL
    Biochemistry; 1995 Jul; 34(28):9177-84. PubMed ID: 7619818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiwavelength videomicrofluorometric study of cytotoxic effects of a marine peptide, didemnin B, on normal and MDR resistant CCRF-CEM cell lines.
    Rocchi E; Vigo J; Viallet P; Bonnard I; Salmon JM
    Anticancer Res; 2000; 20(2A):987-96. PubMed ID: 10810386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice.
    Ueda H; Manda T; Matsumoto S; Mukumoto S; Nishigaki F; Kawamura I; Shimomura K
    J Antibiot (Tokyo); 1994 Mar; 47(3):315-23. PubMed ID: 8175484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor models.
    Zylicz Z; Wagener DJ; van Rennes H; van der Kleijn E; Lelieveld P; van den Broek LA; Ottenheijm HC
    Invest New Drugs; 1988 Dec; 6(4):285-92. PubMed ID: 3229941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure--activity relationships of side-chain modified didemnins.
    Ding X; Vera MD; Liang B; Zhao Y; Leonard MS; Joullié MM
    Bioorg Med Chem Lett; 2001 Jan; 11(2):231-4. PubMed ID: 11206466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytostatic activity of chlamydocin, a rapidly inactivated cyclic tetrapeptide.
    Stähelin H; Trippmacher A
    Eur J Cancer (1965); 1974 Dec; 10(12):801-8. PubMed ID: 4218812
    [No Abstract]   [Full Text] [Related]  

  • 27. Total syntheses and biological investigations of tamandarins A and B and tamandarin A analogs.
    Liang B; Richard DJ; Portonovo PS; Joullié MM
    J Am Chem Soc; 2001 May; 123(19):4469-74. PubMed ID: 11457232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Didemnin B: a new immunosuppressive cyclic peptide with potent activity in vitro and in vivo.
    Montgomery DW; Zukoski CF
    Transplantation; 1985 Jul; 40(1):49-56. PubMed ID: 2409649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental antitumor activity of BMY-28090, a new antitumor antibiotic.
    Schurig JE; Bradner WT; Basler GA; Rose WC
    Invest New Drugs; 1989 Jul; 7(2-3):173-8. PubMed ID: 2793369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Didemnins A and B. Effectiveness against cutaneous herpes simplex virus in mice.
    Weed SD; Stringfellow DA
    Antiviral Res; 1983 Nov; 3(4):269-74. PubMed ID: 6320719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study.
    Weiss RB; Peterson BL; Allen SL; Browning SM; Duggan DB; Schiffer CA
    Invest New Drugs; 1994; 12(1):41-3. PubMed ID: 7960604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group.
    Sondak VK; Kopecky KJ; Liu PY; Fletcher WS; Harvey WH; Laufman LR
    Anticancer Drugs; 1994 Apr; 5(2):147-50. PubMed ID: 8049497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lys3]Didemnins as potential affinity ligands.
    Vera MD; Pfizenmayer AJ; Ding X; Xiao D; Joullié MM
    Bioorg Med Chem Lett; 2001 Jan; 11(1):13-6. PubMed ID: 11140723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Didemnins, tamandarins and related natural products.
    Lee J; Currano JN; Carroll PJ; Joullié MM
    Nat Prod Rep; 2012 Mar; 29(3):404-24. PubMed ID: 22270031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
    Shaker S; Bernstein M; Momparler LF; Momparler RL
    Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total synthesis of a conformationally constrained didemnin B analog.
    Xiao D; Vera MD; Liang B; Joullié MM
    J Org Chem; 2001 Apr; 66(8):2734-42. PubMed ID: 11304195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of didemnin photoaffinity analogues.
    Vera MD; Pfizenmayer AJ; Ding X; Ahuja D; Toogood PL; Joullié MM
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1871-4. PubMed ID: 11459650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 258.